Clinical Trial Update: A Study to Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus Infection [Phase 2]

View source ↗

Summary

Phase 2 study evaluating HH-003 Injection for chronic hepatitis delta virus infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Hepatitis Delta Virus Infection

Drugs mentioned

• HH-003 Injection

Snippet

Sponsor: Huahui Health | Conditions: Chronic Hepatitis Delta Virus Infection | Phase 2 | Status: COMPLETED